مجله سلامت و ورزش: رویکردهای نوین (سورن)

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33.
2. WHO.int.Coronavirus disease (COVID-19) situation dashboard 2020. Available from: https://covid19.who.int/. Acssessed March 2, 2021.
3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199-1207.
4. Schaffer Deroo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA 2020;323(24):2458–9.
5. Plotkin S. History of vaccination. Proc Natl Acad Sci USA 2014;111(34):12283-7.
6. Maserat E, Keikha L, Davoodi S, Mohammadzadeh Z. E-health roadmap for COVID-19 vaccine coverage in Iran. BMC public health 2021;21(1).
7. Meysamie A, Ghasemi E, Moshksar S, Askarian M. Intention to receive COVID-19 vaccine among healthcare workers: a comparison between two surveys. BMC Health Services Research 2022;22(1):1-1.
8. COVID-19 therapies and vaccine landscape. Nat Mater 2020;19(8):809.
9. Jones I, Roy P. Sputnik V COVID-19 vaccine candidate appears safe and effective. Lancet 2021;397(10275):642–3.
10. Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet 2020;396(10267):1979–93.
11. Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, et al. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell 2020;182(3):713-721.
12. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506.
13. Askarian M, Fu L, Taghrir MH, Borazjani R, Shayan Z, Taherifard E, et al. Factors affecting COVID-19 vaccination intent among Iranians: COVID-19 vaccination acceptance. 2020.
14. Ghiasi N, Valizadeh R, Arabsorkhi M, Hoseyni TS, Esfandiari K, Sadighpour T, et al. Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion. Immunopathologia Persa 2021;7(2).
15. Yamamoto F, Cid E, Yamamoto M, Blancher A. ABO research in the modern era of genomics. Transfus Med Rev 2012;26(2):103-18.
16. Cheng Y, Cheng G, Chui CH, Lau FY, Chan PKS, Ng MHL, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA 2005;293(12):1447–1451.
17. Takagi H. Down the Rabbit‐Hole of blood groups and COVID‐19. B J Haem 2020;190:268-270.
18. Boudin L, Janvier F, Bylicki O, Dutasta F. ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults. Haematologica 2020;105(12): 2841-2843.